$VERA SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Fordyce Marshall, Director Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($685K)
15 Sep 2026	8-K: Regulation FD Disclosure; Other Events Exhibit 99.2 Corporate Presentation Sep temb er 2026 © 2026 Vera Therapeutics, Inc. Corporate Presentation
14 Sep 2026	Form 4: Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR Received 5,000 shares by exercise or conversion ($19.7K)
04 Sep 2026	Form 4: Fordyce Marshall, Director Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($650K)
02 Sep 2026	144
14 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	Form 4/A: Fordyce Marshall, Director Received 46,250 shares by exercise or conversion ($134K) · Sold 46,250 shares ($1.96M)
12 Aug 2026	Form 4/A: Fordyce Marshall, Director Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($702K)
12 Aug 2026	Form 4/A: Fordyce Marshall, Director Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($680K)
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
07 Aug 2026	SCHEDULE 13G
05 Aug 2026	Form 4: Boman Nancy Lee, Chief Regulatory Officer Received 44,987 shares as a grant or award · Granted 63,011 Stock Option (right to buy)
05 Aug 2026	Form 3: Boman Nancy Lee, Chief Regulatory Officer No securities owned
30 Jul 2026	SCHEDULE 13G/A
09 Jul 2026	Form 4: Fordyce Marshall, Director Sold 46,250 shares ($1.96M)
09 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
07 Jul 2026	8-K: Other Events
24 Jun 2026	Form 4: Fordyce Marshall, Director Sold 18,500 shares ($702K)
23 Jun 2026	144

Comments